Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perfusion CT for Lung Tumors Treated With SABR
NCT02693080Phase 1Completed
- Sponsor
- Stanford University
- Start
- Jan 2016
- Primary completion
- Apr 2020
- Countries
- 1
01
Overview
Phase 1, open-label trial, sponsored by Stanford University. Primary endpoints: Number of participants able to complete perfusion scan acquisition at the time of treatment-planning, Number of participants able to complete perfusion scan acquisition within 48 hours of SABR and 1 more. Started Jan 2016; status: completed.
Beyond the preview
Go deeper on NCT02693080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693080.